The primary purpose of this study is to report a systematic review of evidence and gaps in the literature among well-conducted studies assessing the impact of diabetes education on hypoglycemia outcomes and secondarily reporting the impact on other included target outcomes.
Methods
The authors used a modified Cochrane method to systematically search and review English-language titles, abstracts, and full-text articles published in the United States between January 2001 and December 2017, with diabetes education specified as an intervention and a directly measurable outcome for hypoglycemia risk or events included.
Results
Fourteen quasi-experimental, experimental, and case-control studies met the inclusion criteria, with 8 articles reporting a positive impact of diabetes self-management education and support (DSMES) on hypoglycemia outcomes; 2 of the 8 reported decreased hypoglycemia events, and 1 reported decreased events in both the intervention and control groups. In addition, 5 studies targeted change in reported hypoglycemia symptoms, with all 5 reporting a significant decrease. DSMES also demonstrated an impact on intermediate (knowledge gain, behavior change) and long-term (humanistic and economic/utilization) outcomes. An absence of common hypoglycemia measures and terminology and suboptimal descriptions of DSMES programs for content, delivery, duration, practitioner types, and participants were identified as gaps in the literature.
Conclusions
Most retained studies reported that diabetes education positively affected varied measures of hypoglycemia outcomes (number of events, reported symptoms) as well as other targeted outcomes. Diabetes education is an important intervention for reducing hypoglycemia events and/or symptoms and should be included as a component of future hypoglycemia risk mitigation studies.
Get full access to this article
View all access options for this article.
References
1.
EdridgeCLDunkleyAJBodicoatDHet al. Prevalence and incidence of hypoglycaemia in 532,542 people with type 2 diabetes on oral therapies and insulin: a systematic review and meta-analysis of population based studies. PLoS One. 2015;10(6):e0126427.
2.
American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care. 2018;41(5):917-928.
3.
DCCT Research Group. Are continuing studies of metabolic control and microvascular complications in insulin-dependent diabetes mellitus justified? The Diabetes Control and Complications Trial. N Engl J Med. 1988;318(4):246-250.
4.
United Kingdom Prospective Diabetes Study Group. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group. Ann Intern Med. 1998;128(3): 165-175.
5.
HandelsmanYBloomgardenZTGrunbergerGet al. American Association of Clinical Endocrinologists and American College of Endocrinology: clinical practice guidelines for developing a diabetes mellitus comprehensive care plan—2015. Endocr Pract. 2015;21(suppl 1):1-87.
LipskaKJRossJSWangYet al. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med. 2014;174(7):1116-1124.
8.
AgiostratidouGAnhaltHBallDet al. Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care. 2017;40(12):1622-1630.
RewersA. Chapter 17: acute metabolic complications in diabetes. In: CowieCCasagrandeSMenkeA eds. Diabetes in America. 3rd ed.Bethesda, MD: National Institutes of Health; 2018:17-11–17-19.
11.
SilbertRSalcido-MontenegroARodriguez-GutierrezRKatabiAMcCoyRG. Hypoglycemia among patients with type 2 diabetes: epidemiology, risk factors, and prevention strategies. Curr Diab Rep. 2018;18(8):53.
12.
US Department of Health and Human Services Office of Disease Prevention and Health Promotion. National Action Plan for Adverse Drug Event Prevention. Washington, DC: US Department of Health and Human Services Office of Disease Prevention and Health Promotion; 2014. https://health.gov/hcq/pdfs/ade-action-plan-508c.pdf. Accessed March 1, 2018.
13.
BasuSBerkowitzSASeligmanH. The monthly cycle of hypoglycemia an observational claims-based study of emergency room visits, hospital admissions, and costs in a commercially insured population. Med Care. 2017;55:639-645.
14.
BerkowitzSAKarterAJLylesCRet al. Low socioeconomic status is associated with increased risk for hypoglycemia in diabetes patients: the Diabetes Study of Northern California (DISTANCE). J Health Care Poor Underserved. 2014;25(2):478-490.
15.
KhuntiKDaviesMMajeedAThorstedBLWoldenMLPaulSK. Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes Care. 2015;38(2):316-322.
16.
GersteinHCMillerMEByingtonRPet al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-2559.
17.
CoxDJGonder-FrederickLASinghHet al. Predicting and reducing driving mishaps among drivers with type 1 diabetes. Diabetes Care. 2017;40(6):742-750.
18.
MooradianADChehadeJM. Diabetes mellitus in older adults. Am J Ther. 2012;19(2):145-159.
19.
JafariBBrittonME. Hypoglycaemia in elderly patients with type 2 diabetes mellitus: a review of risk factors, consequences and prevention. J Pharm Pract Res. 2015;45(4):459-469.
20.
LyTTMaahsDMRewersADungerDOduwoleAJonesTW. ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(suppl 20):180-192.
21.
RingholmLPedersen-BjergaardUThorsteinssonBDammPMathiesenER. Hypoglycaemia during pregnancy in women with type 1 diabetes. Diabet Med. 2012;29(5):558-566.
22.
Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017: Estimates of Diabetes and Its Burden in the United States. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2017https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed January 15, 2019.
23.
BorziVFrassonSGussoniGet al. Risk factors for hypoglycemia in patients with type 2 diabetes, hospitalized in internal medicine wards: findings from the FADOI-DIAMOND study. Diabetes Res Clin Pract. 2016;115:24-30.
24.
AkirovAAmitaiOMasri-IraqiHet al. Predictors of hypoglycemia in hospitalized patients with diabetes mellitus. Intern Emerg Med. 2018;13(3):343-350.
25.
MunshiMNFlorezHHuangESet al. Management of diabetes in long-term care and skilled nursing facilities: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(2):308-318.
26.
NewtonCAAdeelSSadeghi-YarandiSet al. Prevalence, quality of care, and complications in long term care residents with diabetes: a multicenter observational study. J Am Med Dir Assoc. 2013;14(11):842-846.
27.
Beyond A1C Writing Group. Need for regulatory change to incorporate beyond A1C glycemic metrics. Diabetes Care. 2018;41(6):e92-e94.
28.
International Hypoglycaemia Study Group. Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care. 2017;40(1):155-157.
29.
StrawbridgeLMLloydJTMeadowARileyGFHowellBL. Use of Medicare’s diabetes self-management training benefit. Health Educ Behav. 2015;42(4):530-538.
30.
PowersMABardsleyJCypressMet al. Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Diabetes Educ. 2015;41(4):417-430.
31.
BeckJGreenwoodDABlantonLet al. 2017 National standards for diabetes self-management education and support. Diabetes Educ. 2017;43(5):449-464.
32.
PowersMABardsleyJCypressMet al. Diabetes self-management education and support in type 2 diabetes. Diabetes Educ. 2017;43(1):40-53.
StrawbridgeLMLloydJTMeadowARileyGFHowellBL. One-year outcomes of diabetes self-management training among medicare beneficiaries newly diagnosed with diabetes. Med Care. 2017;55(4):391-397.
35.
Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions: Version 5.1.0. http://handbook-5–1.cochrane.org/. Published 2011. Accessed March 1, 2018.
36.
NathanDMClearyPABacklundJYet al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643-2653.
MoherDLiberatiATetzlaffJAltmanDG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
45.
CollierIABakerDM. Implementation of a pharmacist-supervised outpatient diabetes treatment clinic. Am J Health Syst Pharm. 2014;71(1):27-36.
46.
FishLHWetzlerHPDavidsonJLOfsteadCLJohnsonML. Advanced insulin management program reduces A1C levels and regimen-related distress without weight gain in patients with type 1 diabetes mellitus. Insulin. 2008;3:59-66.
47.
LorigKRitterPLTurnerRMEnglishKLaurentDDGreenbergJ. Benefits of diabetes self-management for health plan members: a 6-month translation study. J Med Internet Res. 2016;18(6):e164.
48.
LorigKRitterPLTurnerRMEnglishKLaurentDDGreenbergJ. A diabetes self-management program: 12-month outcome sustainability from a nonreinforced pragmatic trial. J Med Internet Res. 2016;18(12):e322.
49.
MageeMFNassarCMCopelandJet al. Synergy to reduce emergency department visits for uncontrolled hyperglycemia. Diabetes Educ. 2013;39(3):354-364.
50.
PyatakEASequeiraPAVigenCLet al. Clinical and psychosocial outcomes of a structured transition program among young adults with type 1 diabetes. J Adolesc Health. 2017;60(2):212-218.
51.
SequeiraPAPyatakEAWeigensbergMJet al. Let’s Empower and Prepare (LEAP): evaluation of a structured transition program for young adults with type 1 diabetes. Diabetes Care. 2015;38(8):1412-1419.
52.
TomiokaMBraunKLAh CookVComptonMWertinK. Improving behavioral and clinical indicators in Asians and Pacific Islanders with diabetes: findings from a community clinic-based program. Diabetes Res Clin Pract. 2014;104(2):220-225.
53.
LorigKRitterPLVillaFPietteJD. Spanish diabetes self-management with and without automated telephone reinforcement: two randomized trials. Diabetes Care. 2008;31(3):408-414.
MageeMFNassarCMMeteMWhiteKYoussefGADubinJS. The synergy to enable glycemic control following emergency department discharge program for adults with type 2 diabetes: STEP-DIABETES. Endocr Pract. 2015;21(11):1227-1239.
56.
OyerDSShepherdMDCoulterFCet al. A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial). Am J Med. 2009;122(11):1043-1049.
57.
DalalMRRobinsonSBSullivanSD. Real-world evaluation of the effects of counseling and education in diabetes management. Diabetes Spectr. 2014;27(4):235-243.
58.
SullivanSDDalalMRBurkeJP. The impact of diabetes counseling and education: clinical and cost outcomes from a large population of US managed care patients with type 2 diabetes. Diabetes Educ. 2013;39(4):523-531.
BaigAABenitezAQuinnMTBurnetDL. Family interventions to improve diabetes outcomes for adults. Ann N Y Acad Sci. 2015;1353:89-112.
61.
ShiMXuMYLiuZLet al. Effectiveness of family involvement in newly diagnosed type 2 diabetes patients: a follow-up study. Patient Educ Couns. 2016;99(5):776-782.
62.
ClementsMAFosterNCMaahsDMet al. Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry. Pediatr Diabetes. 2016;17(5):327-336.
63.
ChiangJLKirkmanMSLaffelLMPetersAL. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care. 2014;37(7):2034-2054.
64.
KargesBRosenbauerJKapellenTet al. Hemoglobin A1c levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012. PLoS Med. 2014;11(10):e1001742.
65.
McGillDELevitskyLL. Management of hypoglycemia in children and adolescents with type 1 diabetes mellitus. Curr Diab Rep. 2016;16(88):1-6.
66.
ShalimovaAGraffBGaseckiDet al. Cognitive dysfunction in type 1 diabetes mellitus. Clin Endocrinol Metab. 2019;104(6):2239-2249.
67.
LitchmanMLAllenNAColicchioVDet al. A qualitative analysis of real-time continuous glucose monitoring data sharing with care partners: to share or not to share?Diabetes Technol Ther. 2018;20(1):25-31.
68.
AminALauLCrawfordSEdwardsAPacaudD. Prospective assessment of hypoglycemia symptoms in children and adults with type 1 diabetes. Can J Diabetes. 2014;38(4):263-268.
69.
IqbalAHellerSR. The role of structured education in the management of hypoglycemia. Diabetologia. 2018;61:751-760.
70.
YorkeEAtiaseY. Impact of structured education on glucose control and hypoglycaemia in type-2 diabetes: a systematic review of randomized controlled trials. Ghana Med J. 2018;52(1):41-60.
KampsJLRobertsMCVarelaRE. Development of a new fear of hypoglycemia scale: preliminary results. J Pediatr Psychol. 2005;30(3):287-291.
73.
Anarte OrtizMTCaballeroFFRuiz de AdanaMSet al. Development of a new fear of hypoglycemia scale: FH-15. Psychol Assess. 2011;23(2):398-405.
74.
Gonder-FrederickLASchmidtKMVajdaKAet al. Psychometric properties of the Hypoglycemia Fear Survey-II for adults with type 1 diabetes. Diabetes Care. 2011;34(4):801-806.
75.
KarterAJWartonMLipskaKJet al. Development and validation of a tool to identify patients with type 2 diabetes at high risk of hypoglycemia-related emergency department or hospital use. JAMA Intern Med. 2017;177(10):1461-1470.
76.
PolonskyWHFisherLHesslerDEdelmanSV. Investigating hypoglycemic confidence in type 1 and type 2 diabetes. Diabetes Technol Ther. 2017;19(2):131-136.
77.
Diabetes program focuses on the basics. Hosp Case Manag. 2016;24(2):23-25.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
